Feasibility of Using Boltzmann Plots to Evaluate the Stark Broadening Parameters of Cu(I) Lines.

A linear Boltzmann plot was constructed using Cu(I) lines of well-known atomic parameters. Aligning other spectral lines to the plot was adopted as a viable way to estimate the most probable values of Stark broadening parameters of Cu(I) lines at 330.79, 359.

P53 rs1042522 and CD95 rs1800682 genetic variations in HCV-4a response to antiviral therapy.

Current estimates indicate that the hepatitis C (HCV) is the leading cause of mortality around the world, with infection rates steadily increasing in Egypt. The dual therapy for this silent epidemic with pegylated-interferon-α2b/ribavirin has markedly improved the success rates in genotype-4 patients. It was reported that apoptosis plays a vital mechanistic role in limiting viral replication.

The potential impact of P53 and APO-1 genetic polymorphisms on hepatitis C genotype 4a susceptibility.

The hepatitis C virus (HCV), the main cause of morbidity and mortality, is endemic worldwide. HCV causes cirrhosis and other complications that often lead to death. HCV is most common in underdeveloped nations, with the highest prevalence rates in Egypt.

"P53 codon 72 single base substitution in viral hepatitis C and hepatocarcinoma incidences".

Viral infection with hepatitis C virus (HCV) has a high propensity in becoming chronic and it is the major cause of hepatocellular carcinoma (HCC) worldwide. This review was basically established to illustrate the putative role of the P53 gene Arg72Pro polymorphism on various cancer models and viral infections, focusing on HCV and HCC incidences. Authors studied the 72 G/C single base substitution of P53 gene at codon 72 using various polymorphic techniques.

Correlation and multiple regression analyses of pituitary growth hormone and hepatic activities in hepatitis C infection and interferon response.

The prevalence of hepatitis C virus (HCV) infection varies across the world, with the highest percent of infections reported in Middle East, increasingly in Egypt. The current study aimed at examining the bio-statistical correlation and multiple regression analyses of pituitary growth hormone (GH) and liver activities among HCV genotype-4 patients treated with PEG-IFN-α plus RBV therapy. Herein, the current study was conducted on 100 HCV genotype-4 infected patients and 50 healthy controls.